Irbit Chemical Pharmaceutical Plant Receives UAE GMP Certificate

Irbit Chemical Pharmaceutical Plant (part of the production division of Avexima) has successfully passed an inspection for compliance with the Good Manufacturing Practice (GMP) requirements of the United Arab Emirates.

«The GMP certificate issued by the UAE side confirms that the production processes at Irbit Chemical Pharmaceutical Plant meet international quality standards and opens up new opportunities for us to develop export shipments of pharmaceutical products. Obtaining the certificate is an important milestone in the implementation of Avexima's export strategy and lays the groundwork for further expansion of cooperation with partners in the Middle East», emphasized Ivan Khalepo, General Director of Avexima.

Irbit Chemical Pharmaceutical Plant JSC is one of Russia's oldest pharmaceutical enterprises, possessing the unique advantage of full-cycle production — from the development of active pharmaceutical ingredients to the output of finished dosage forms. Its site annually produces 135 tonnes of pharmaceutical substances, over 2 billion tablets, and 135 million capsules. The plant is equipped with modern machinery and is certified in accordance with the requirements of international GMP quality standards.